Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder.

Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone SV, Seidman L.

Am J Psychiatry. 1998 May;155(5):693-5.

PMID:
9585725
2.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
3.

Pharmacological treatments for ADHD and the novel agent atomoxetine.

Bailey KP.

J Psychosoc Nurs Ment Health Serv. 2003 Aug;41(8):12-7. Review. No abstract available.

PMID:
13677007
4.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
5.

Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.

Simpson D, Plosker GL.

Drugs. 2004;64(2):205-22. Review.

PMID:
14717619
6.

Tomoxetine (Eli Lilly & Co).

Preti A.

Curr Opin Investig Drugs. 2002 Feb;3(2):272-7. Review.

PMID:
12020059
7.

Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder.

Caballero J, Nahata MC.

Clin Ther. 2003 Dec;25(12):3065-83. Review.

PMID:
14749146
8.

Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder.

Simpson D, Plosker GL.

CNS Drugs. 2004;18(6):397-401. Review.

PMID:
15089111
9.

Atomoxetine.

Simpson D, Perry CM.

Paediatr Drugs. 2003;5(6):407-15; discussion 416-7. Review. Erratum in: Paediatr Drugs. 2003;5(10):661. Dosage error in article text.

PMID:
12765489
10.

The use of antidepressants to treat attention deficit hyperactivity disorder in adults.

Maidment ID.

J Psychopharmacol. 2003 Sep;17(3):332-6. Review.

PMID:
14513926

Supplemental Content

Support Center